Intelligent Bio Solutions Inc. Common Stock (INBS) is a publicly traded Healthcare sector company. As of November 4, 2026, INBS trades at $1.76 with a market cap of $5.51M and a P/E ratio of -0.20. INBS moved -0.62% today. Year to date, INBS is -77.69%; over the trailing twelve months it is -81.02%. Its 52-week range spans $1.35 to $24.90. Rallies surfaces INBS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for INBS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $1.76 |
| Market Cap | $5.51M |
| P/E Ratio | -0.20 |
| EPS | $-8.44 |
| Dividend Yield | 0.00% |
| 52-Week High | $24.90 |
| 52-Week Low | $1.35 |
| Volume | 1.94K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.22M |
| Net Income | $-12.47M |
| Gross Margin | 48.63% |
INBS analyst coverage data. Average price target: $0.00.